Translational control and the cancer cell response to stress
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The evidence for the importance of aberrant translation in cancer cells is overwhelming. Reflecting the wealth of data, there are excellent reviews delineating how ribosomes and initiation factors are linked to cancer [1-3], and the therapeutic strategies being devised to target them [4]. Changes in translational efficiency can engender a malignant phenotype without the need for chromatin reorganization, transcription, splicing and mRNA export [5,6]. Thus, cancer-related modulations of the translational machinery are ideally suited to allow cancer cells to respond to the various stresses encountered along the path of tumorigenesis and organism-wide dissemination [7•,8,9,10•]. Emerging findings supporting this notion are the focus of this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Vogel, C., & Marcotte, E. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3185 · Cited by 4,195
Ingolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
Rolfe, D. F., & Brown, G. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.731 · Cited by 2,021
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Vyas, S., Zaganjor, E., & Haigis, M. C. (2016) · Cell · doi:10.1016/j.cell.2016.07.002 · Cited by 1,735 · cited 1×
“Energetic stress Low levels of oxygen and/or nutrients can prevent proper energy production by cancer cells, as can mitochondrial damage and chemical inhibitors of oxidative phosphorylation [68].”
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313 · cited 1×
“Key translational targets have been identified, and technologies allowing genome-wide analysis of translation are opening new avenues of research and promising therapeutic strategies [28,85].”
Nutrient-sensing mechanisms and pathways
Efeyan, A., Comb, W. C., & Sabatini, D. M. (2015) · Nature · doi:10.1038/nature14190 · Cited by 1,110 · cited 1×
“Consistent with this, both the eIF2a and eIF4E branches are independently inhibited during hypoxia and nutrient depravation to restrict protein synthesis, though the sensors of each stress vary (see Figure 1) [54].”
Translational control by 5′-untranslated regions of eukaryotic mRNAs
Hinnebusch, A. G., Ivanov, I. P., & Sonenberg, N. (2016) · Science · doi:10.1126/science.aad9868 · Cited by 1,079
Self-citationLu, P. D., Harding, H. P., & Ron, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408003 · Cited by 1,006 · cited 1×
“ATF4 is the major transcription factor initiating the integrated stress response, however, its expression depends on translational regulation by eIF2a phosphorylation, which is mediated by upstream open reading frames (uORFs) [19] (see references [2,20] for more information on this and the scanning mechanism of transl…”
Morita, M., Gravel, S.-P., Chénard, V., Sikström, K., Zheng, L., Alain, T., Gandin, V., Avizonis, D., Arguello, M., Zakaria, C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.001 · Cited by 842 · cited 1×
“In turn, many mitochondrial proteins are regulated at the level of translation [70,71].”
Self-citationTargeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799 · cited 4×
“Despite the importance of translation in cancer, its targeting in cancer patients has not been achieved, notwithstanding some notable benefits of rapamycin analogs [4].”
InfluentialSelf-citationMarguerat, S., Schmidt, A., Codlin, S., Chen, W., Aebersold, R., & Bähler, J. (2012) · Cell · doi:10.1016/j.cell.2012.09.019 · Cited by 571
New frontiers in translational control of the cancer genome
Truitt, M. L., & Ruggero, D. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.27 · Cited by 378
An oxygen-regulated switch in the protein synthesis machinery
Uniacke, J., Holterman, C. E., Lachance, G., Franovic, A., Jacob, M. D., Fabian, M. R., Payette, J., Holcik, M., Pause, A., & Lee, S. (2012) · Nature · doi:10.1038/nature11055 · Cited by 319 · cited 1×
“reported that eIF4E2, also known as 4EHP, serves as an alternative cap-binding protein and recruits ribosomes via an alternative initiation complex [58].”
Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
Xu, Y., Li, N., Xiang, R., & Sun, P. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.04.004 · Cited by 282
The rate of protein synthesis in hematopoietic stem cells is limited partly by 4E-BPs
Signer, R. A. J., Qi, L., Zhao, Z., Thompson, D., Sigova, A. A., Fan, Z. P., DeMartino, G. N., Young, R. A., Sonenberg, N., & Morrison, S. J. (2016) · Genes & Development · doi:10.1101/gad.282756.116 · Cited by 115 · cited 1×
“For example, embryotic stem cells (ESCs), as well as several adult stem cells, undergo drastic changes in global translation and in the translation of specific mRNAs at early stages of differentiation [16,17].”
Self-citationBeggs, J. E., Tian, S., Jones, G. G., Xie, J., Iadevaia, V., Jenei, V., Thomas, G., & Proud, C. G. (2015) · Biochemical Journal · doi:10.1042/bj20141066 · Cited by 65
Research works printed but not linked: 75
- Gentilella, 2015, A liaison between mTOR signaling, ribosome biogenesis and cancer, Biochim. Biophys. Acta, 1849, 812, 10.1016/j.bbagrm.2015.02.005 · DOI
- Ruggero, 2013, Translational control in cancer etiology, Cold Spring Harb. Perspect. Biol., 5, 10.1101/cshperspect.a012336 · DOI · Paper page
- Spriggs, 2010, Translational regulation of gene expression during conditions of cell stress, Mol. Cell, 40, 228, 10.1016/j.molcel.2010.09.028 · DOI · Paper page
- de Nadal, 2011, Controlling gene expression in response to stress, Nat. Rev. Genet., 12, 833, 10.1038/nrg3055 · DOI · Paper page
- Truitt, 2015, Differential requirements for eIF4E dose in normal development and cancer, Cell, 162, 59, 10.1016/j.cell.2015.05.049 · DOI · Paper page
- Martinez, 2015, Phosphorylation of eIF4E confers resistance to cellular stress and DNA-damaging agents through an interaction with 4E-T: a rationale for novel therapeutic approaches, PLoS One, 10, e0123352, 10.1371/journal.pone.0123352 · DOI
- Chen, 2010, Differential regulation of CHOP translation by phosphorylated eIF4E under stress conditions, Nucleic Acids Res., 38, 764, 10.1093/nar/gkp1034 · DOI
- Avdulov, 2015, eIF4E threshold levels differ in governing normal and neoplastic expansion of mammary stem and luminal progenitor cells, Cancer Res., 75, 687, 10.1158/0008-5472.CAN-14-2571 · DOI
- Buttgereit, 1995, A hierarchy of ATP-consuming processes in mammalian cells, Biochem. J., 312, 163, 10.1042/bj3120163 · DOI · Paper page
- Tahmasebi, 2016, Control of embryonic stem cell self-renewal and differentiation via coordinated alternative splicing and translation of YY2, Proc. Natl. Acad. Sci. U. S. A., 10.1073/pnas.1615540113 · DOI
- Lazaris-Karatzas, 1990, Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap, Nature, 345, 544, 10.1038/345544a0 · DOI · Paper page
- De Benedetti, 1999, eIF4E expression in tumors: its possible role in progression of malignancies, Int. J. Biochem. Cell Biol., 31, 59, 10.1016/S1357-2725(98)00132-0 · DOI · Paper page
- Oblinger, 2016, Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas, Neuro Oncol., 18, 1265, 10.1093/neuonc/now032 · DOI
- Martinez-Saez, 2016, peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas, Cancer Med., 5, 2501, 10.1002/cam4.817 · DOI
- Jiang, 2016, Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma, J. Cancer Res. Clin. Oncol., 142, 2309, 10.1007/s00432-016-2232-2 · doi:10.1007/s00432-016-2232-2
- Carter, 2016, Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma, Br. J. Cancer, 114, 444, 10.1038/bjc.2015.450 · DOI
- Gandin, 2016, nanoCAGE reveals 5′ UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs, Genome Res., 26, 636, 10.1101/gr.197566.115 · DOI · Paper page
- Koromilas, 2015, Roles of the translation initiation factor eIF2alpha serine 51 phosphorylation in cancer formation and treatment, Biochim. Biophys. Acta, 1849, 871, 10.1016/j.bbagrm.2014.12.007 · DOI
- Wang, 1999, Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin’s lymphomas, Am. J. Pathol., 155, 247, 10.1016/S0002-9440(10)65118-8 · doi:10.1016/s0002-9440(10)65118-8
- Rosenwald, 2001, Expression of eukaryotic translation initiation factors 4E and 2alpha is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung, Cancer, 92, 2164, 10.1002/1097-0142(20011015)92:8<2164::AID-CNCR1559>3.0.CO;2-A · doi:10.1002/1097-0142(20011015)92:8<2164::aid-cncr1559>3.0.co;2-a
- Kim, 2002, Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR, Oncogene, 21, 8741, 10.1038/sj.onc.1205987 · DOI
- Ye, 2010, The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation, EMBO J., 29, 2082, 10.1038/emboj.2010.81 · DOI · Paper page
- Kozel, 2016, Overexpression of eIF5 or its protein mimic 5MP perturbs eIF2 function and induces ATF4 translation through delayed re-initiation, Nucleic Acids Res., 44, 8704, 10.1093/nar/gkw559 · DOI
- Gandin, 2016, mTORC1 and CK2 coordinate ternary and eIF4F complex assembly, Nat. Commun., 7, 11127, 10.1038/ncomms11127 · DOI · Paper page
- Rajesh, 2015, Phosphorylation of the translation initiation factor eIF2alpha at serine 51 determines the cell fate decisions of Akt in response to oxidative stress, Cell Death Dis., 6, e1591, 10.1038/cddis.2014.554 · DOI
- Dennis, 2013, Regulated in DNA damage and development 1 (REDD1) promotes cell survival during serum deprivation by sustaining repression of signaling through the mechanistic target of rapamycin in complex 1 (mTORC1), Cell Signal., 25, 2709, 10.1016/j.cellsig.2013.08.038 · DOI
- Whitney, 2009, ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression, Biochem. Biophys. Res. Commun., 379, 451, 10.1016/j.bbrc.2008.12.079 · DOI · Paper page
- Ruggero, 2004, The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis, Nat. Med., 10, 484, 10.1038/nm1042 · DOI · Paper page
- Petroulakis, 2009, p53-dependent translational control of senescence and transformation via 4E-BPs, Cancer Cell, 16, 439, 10.1016/j.ccr.2009.09.025 · DOI
- Larsson, 2007, Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors, Cancer Res., 67, 6814, 10.1158/0008-5472.CAN-07-0752 · DOI · Paper page
- Musa, 2016, Dual mTORC1/2 inhibition as a novel strategy for the resensitization and treatment of platinum-resistant ovarian cancer, Mol. Cancer Ther., 15, 1557, 10.1158/1535-7163.MCT-15-0926 · DOI
- Larsson, 2006, Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure, Nucleic Acids Res., 34, 4375, 10.1093/nar/gkl558 · DOI · Paper page
- Lazaris-Karatzas, 1992, The mRNA 5′ cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts, Mol. Cell Biol., 12, 1234
- Rinker-Schaeffer, 1993, Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts, Int. J. Cancer, 55, 841, 10.1002/ijc.2910550525 · DOI · Paper page
- Rajesh, 2013, eIF2alpha phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies, Aging (Albany NY), 5, 884, 10.18632/aging.100620 · DOI
- Horiguchi, 2012, Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors, Cancer Res., 72, 395, 10.1158/0008-5472.CAN-11-1891 · DOI · Paper page
- Bengsch, 2015, Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts, Cell Cycle, 14, 1540, 10.1080/15384101.2015.1026492 · DOI
- Koritzinsky, 2006, Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control, EMBO J., 25, 1114, 10.1038/sj.emboj.7600998 · DOI · Paper page
- Bennewith, 2004, Quantifying transient hypoxia in human tumor xenografts by flow cytometry, Cancer Res., 64, 6183, 10.1158/0008-5472.CAN-04-0289 · DOI · Paper page
- Lehman, 2015, Translational upregulation of an individual p21Cip1 transcript variant by GCN2 regulates cell proliferation and survival under nutrient stress, PLoS Genet., 11, e1005212, 10.1371/journal.pgen.1005212 · DOI · Paper page
- Leprivier, 2015, Stress-mediated translational control in cancer cells, Biochim. Biophys. Acta, 1849, 845, 10.1016/j.bbagrm.2014.11.002 · DOI
- Braunstein, 2007, A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer, Mol. Cell, 28, 501, 10.1016/j.molcel.2007.10.019 · DOI · Paper page
- Joshi, 2004, Characterization of mammalian eIF4E-family members, Eur. J. Biochem., 271, 2189, 10.1111/j.1432-1033.2004.04149.x · DOI · Paper page
- Zuberek, 2007, Weak binding affinity of human 4EHP for mRNA cap analogs, RNA, 13, 691, 10.1261/rna.453107 · DOI
- Lee, 2016, eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation, Nature, 536, 96, 10.1038/nature18954 · DOI · Paper page
- Connolly, 2006, Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells, Mol. Cell Biol., 26, 3955, 10.1128/MCB.26.10.3955-3965.2006 · DOI · Paper page
- Yi, 2013, Hypoxia-inducible factor-1alpha (HIF-1alpha) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions, J. Biol. Chem., 288, 18732, 10.1074/jbc.M113.471466 · DOI · Paper page
- Nathan, 1997, Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas, Oncogene, 15, 1087, 10.1038/sj.onc.1201272 · DOI
- Scott, 1998, Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E, Br. J. Cancer, 77, 2120, 10.1038/bjc.1998.356 · DOI
- Dodd, 2015, mTORC1 drives HIF-1alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3, Oncogene, 34, 2239, 10.1038/onc.2014.164 · DOI · Paper page
- Frydryskova, 2016, Distinct recruitment of human eIF4E isoforms to processing bodies and stress granules, BMC Mol. Biol., 17, 21, 10.1186/s12867-016-0072-x · DOI
- Zucal, 2015, EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition, BMC Cancer, 15, 855, 10.1186/s12885-015-1845-1 · DOI
- Larsson, 2012, Distinct perturbation of the translatome by the antidiabetic drug metformin, Proc. Natl. Acad. Sci. U. S. A., 109, 8977, 10.1073/pnas.1201689109 · DOI · Paper page
- Tamarkin-Ben-Harush, 2017, Cap-proximal nucleotides via differential eIF4E binding and alternative promoter usage mediate translational response to energy stress, Elife, 6, 10.7554/eLife.21907 · DOI · Paper page
- Dong, 2009, Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells, Breast Cancer Res. Treat., 113, 443, 10.1007/s10549-008-9956-x · DOI
- Zhou, 2011, Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells, Med. Oncol., 28, 1302, 10.1007/s12032-010-9630-0 · DOI
- Boussemart, 2014, eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies, Nature, 10.1038/nature13572 · DOI · Paper page
- Yu, 2016, eIF4E-phosphorylation-mediated Sox2 upregulation promotes pancreatic tumor cell repopulation after irradiation, Cancer Lett., 375, 31, 10.1016/j.canlet.2016.02.052 · DOI
- Grzmil, 2016, Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy, Cell Signal., 28, 1412, 10.1016/j.cellsig.2016.06.005 · DOI
- Jeon, 2016, Salubrinal-mediated upregulation of eIF2alpha phosphorylation increases doxorubicin sensitivity in MCF-7/ADR cells, Mol. Cells, 39, 129, 10.14348/molcells.2016.2243 · DOI
- Schewe, 2009, Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy, Cancer Res., 69, 1545, 10.1158/0008-5472.CAN-08-3858 · DOI
- Pola, 2013, Vitronectin-alphavbeta3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells, Cancer Res., 73, 4571, 10.1158/0008-5472.CAN-13-0218 · DOI
- Gorrini, 2005, Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways, Proc. Natl. Acad. Sci. U. S. A., 102, 9200, 10.1073/pnas.0409513102 · DOI
- Nasr, 2013, eIF4F suppression in breast cancer affects maintenance and progression, Oncogene, 32, 861, 10.1038/onc.2012.105 · DOI · Paper page
- Robichaud, 2015, Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3, Oncogene, 34, 2032, 10.1038/onc.2014.146 · DOI · Paper page
- Ghosh, 2009, Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation, ACS Chem. Biol., 4, 367, 10.1021/cb9000475 · DOI · Paper page
- Pettersson, 2015, Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis, Cancer Res., 75, 1102, 10.1158/0008-5472.CAN-14-1996 · DOI
- Grzmil, 2011, MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-beta signaling pathway in human glioblastoma, Cancer Res., 71, 2392, 10.1158/0008-5472.CAN-10-3112 · DOI
- Graff, 2009, eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival, Cancer Res., 69, 3866, 10.1158/0008-5472.CAN-08-3472 · DOI · Paper page
- Lee, 2015, Prognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer, Int. J. Clin. Exp. Pathol., 8, 3955
- Heikkinen, 2013, Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment, Breast Cancer Res. Treat., 141, 79, 10.1007/s10549-013-2671-2 · DOI
- Campbell, 2015, Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma, Am. J. Cancer Res., 5, 2838
- Mujcic, 2013, Hypoxic activation of the PERK/eIF2alpha arm of the unfolded protein response promotes metastasis through induction of LAMP3, Clin. Cancer Res., 19, 6126, 10.1158/1078-0432.CCR-13-0526 · DOI · Paper page
- Hong, 2011, A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer, Clin. Cancer Res., 17, 6582, 10.1158/1078-0432.CCR-11-0430 · DOI · Paper page
- Duffy, 2016, Modulation of tumor eIF4E by antisense inhibition: a phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer, Int. J. Cancer, 139, 1648, 10.1002/ijc.30199 · DOI
Cited by
Translational Control in Cancer
Robichaud, N., Sonenberg, N., Ruggero, D., & Schneider, R. J. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032896 · Cited by 302
Self-citationYang, J.-Y., Deng, X.-Y., Li, Y.-S., Ma, X.-C., Feng, J.-X., Yu, B., Chen, Y., Luo, Y.-L., Wang, X., Chen, M.-L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03544-x · Cited by 124
Kasteri, J., Das, D., Zhong, X., Persaud, L., Francis, A., Muharam, H., & Sauane, M. (2018) · Cancers · doi:10.3390/cancers10050133 · Cited by 24
Rapid cell type-specific nascent proteome labeling in Drosophila
Villalobos-Cantor, S., Barrett, R. M., Condon, A. F., Arreola-Bustos, A., Rodriguez, K. M., Cohen, M. S., & Martin, I. (2023) · eLife · doi:10.7554/elife.83545 · Cited by 13
Metadata
- Authors
- Robichaud, N., & Sonenberg, N.
- Venue
- Current Opinion in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 45
- Pages
- 102-109
- ISSN
- 0955-0674 (ISSN-L)
- OpenAlex
- W2621232571
- Cited by
- 70
- References
- 20
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.